B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses

J Neuroimmunol. 2016 Feb 15:291:46-53. doi: 10.1016/j.jneuroim.2015.11.022. Epub 2015 Nov 26.

Abstract

B cells are highly potent antigen presenting cells of their cognate antigens. However, it remains unknown whether B cells can orchestrate Th17-mediated responses against neuro-antigens. We report that MS patients and healthy donors had a similar frequency of antigen-specific Th1 and Th17 cells, and distribution of T effector and T central memory cells. Notwithstanding these similarities, the application of an in vitro assay demonstrated that the B cells derived from a subset of MS patients exhibited the capability of coordinating Th17 responses directed toward neuro-antigens. These observations underscore the B cell's contribution to the putative underpinnings of multiple sclerosis.

Keywords: B cells; Multiple sclerosis; Th17 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • B-Lymphocytes / physiology*
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology
  • Cells, Cultured
  • Coculture Techniques
  • Cytokines / metabolism
  • Female
  • Flow Cytometry
  • Humans
  • Lymphocyte Activation
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / pathology*
  • Myelin Basic Protein / immunology
  • Myelin Basic Protein / pharmacology*
  • Myelin-Oligodendrocyte Glycoprotein / immunology*
  • Myelin-Oligodendrocyte Glycoprotein / pharmacology
  • Th17 Cells / drug effects
  • Th17 Cells / metabolism*

Substances

  • Antigens, CD
  • Cytokines
  • Myelin Basic Protein
  • Myelin-Oligodendrocyte Glycoprotein